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RESUMO
Introdução. A qualidade de vida nos pacientes com doença de 
Parkinson (DP) está relacionada ao estágio da doença e altera 
também a qualidade de vida dos cuidadores que convivem com 
eles. Método. Foram avaliados consecutivamente 43 pacientes 
com DP (31 homens) e seus respectivos cuidadores (35 mulheres) 
para definir se os sintomas da doença influenciam na qualidade 
de vida dos indivíduos analisados. Resultados. Houve correla-
ção significante entre a qualidade de vida e as medidas de gra-
duação da doença e o stress dos cuidadores, sendo que quanto 
maior a pontuação nas escalas de estágio da doença, pior a qua-
lidade de vida dos pacientes e seus cuidadores. Conclusão. O 
controle dos sintomas da doença ajuda a melhorar a qualidade 
de vida dos pacientes e, consequentemente, de seus cuidadores.
Unitermos. Doença de Parkinson, Qualidade de Vida, 
Assistência ao Paciente.
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SUMMARY
Introduction. The quality of life in patients with Parkinson’s 
disease (PD) is related to the disease level, which also indicates 
the caregiver’s quality of life. Methods. This study comprised 
43 patients with PD (31 male) and their respective caregivers 
(35 female) in order to evaluate if these disease symptoms may 
change their quality of life. Results. There was a statistically 
significant correlation between quality of life and the disease le-
vel and caregiver stress. The higher the score of disease level, the 
worse the patients and caregivers’ quality of life. Conclusion. 
The disease control improves the patients’ quality of life and, 
consequently, the caregivers’ quality of life.
Keywords. Parkinson Disease, Quality of Life, Patient 
Care.
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INTRODUCTION
The Parkinson’s disease (PD) is a chronic and 
degenerative disorder of  the Central Nervous System, 
and may lead to a high degree of  incapability and 
difficulty to write, interfering with the patients’ daily 
functions. Their customs and emotions, as well as the 
environment where they have lived are changed1.
The patients need caregivers to help them 
from the simplest to the most complex functions, al-
tering their daily routine2-4.
Due to these changes, patients and caregivers 
are exposed to stress, irritability, and psychosomatic 
disease, as depression, which may affect among 30 
and 70% of  the patients with PD, damaging their 
quality of  life5-7.
The concept of  quality of  life is subjective and 
is related to physical, psychological and social com-
fort8,9. While the patient’s physical aspect includes 
medication and symptoms, the disease’s stage, time 
of  evolution and comorbidity, the emotional aspect 
includes felling, belief, expectation and perception of  
the patient themselves, the disease acceptance, and 
self-attention9-12.
Considering that the patients’ relation with 
their families may not be adequate, the patients’ 
psychomotor capability may be underestimated and 
completely neglected by their caregivers. Everything 
may be caused for high levels of  stress and default of  
information about the illness and its treatment, and 
this may cause deterioration in the quality of  life of  
patients with PD.
Therefore, the family should be informed 
about the fluctuation in the action of  the medica-
tion, which may cause discomfort and variation in 
the patients’ humor and temper13.
One way to improve the patient’s quality of  
life is to stimulate his living in society, by the family, 
other people, and other patients. Therefore, the fam-
ily’s role is to stimulate and to facilitate the commu-
nication of  the patient with PD, avoiding that they 
immure themselves socially and develop depression. 
Everything should be performed in order to improve 
the patients’ well being14.
The objectives of  this study were to evaluate 
the quality of  life of  patients with PD; measure the 
caregivers’ stress level; and to confront the caregiv-
ers’ stress levels with the patients’ quality of  life, re-
lating them to the disease gradation.
METHOD
During the period July 2003 to July 2004, 43 
patients diagnosed with PD and their caregivers were 
interviewed, consecutively followed up at the Move-
ment Disorders Outpatient Unit of  the Department 
of  Neurology, State University of  Campinas Teach-
ing Hospital (HC/Unicamp). The PD diagnosis was 
based on the London Brain Bank criteria15.
All patients were evaluated during phase “on”, 
just with effect of  antiparkinsonian medication. 
The exclusion criteria were having undergone 
neurosurgery to provisory decrease of  the disease 
symptoms, and presence of  dementia.
The disease degree was evaluated by using the 
following scales: UPDRS (Unified Parkinson’s Dis-
ease Rating Scale), Hoehn & Yahr scale, and Schwab 
& England scale16.
The patient’s quality of  life was evaluated by 
using the PD questionnaire (PDQ-39), which estimat-
ed the disease impact on the patient’s health and well 
being, with scores ranging from 37-185 points. The 
higher is the score, the worse the patient’s health is17.
The caregivers were defined as the closest 
people with the patients, helping them in their daily 
activities, independent of  relationship degree5. They 
had their stress levels measured by the Caregiver 
Stress Scale (CSS), ranging from 25-125 points18.
The Research Ethics Committee of  the Faculty 
of  Medical Sciences of  Unicamp approved this study, 
and the patients and caregivers were informed as to 
the evaluation objectives and signed a consent term.
Table 1. Frequency of  patients and caregivers to every age.
Age (years) Patients Caregivers
< 30 0 (0.0%) 4 (9.3%)
30-39 0 (0.0%) 3 (7.0%)
40-49 6 (14.0%) 10 (23.3%)
50-59 11 (25.6%) 15 (34.9%)
60-69 11 (25.6%) 8 (18.6%)
> 70 15 (34.9%) 3 (7.0%)
Total 43 (100%) 43 (100%)
Table 2. Frequency of  patients in each score of  classification of  Hoehn 
& Yahr.
Hoehn & Yahr Frequency
1.0 0 (0.0%)
1.5 3 (7.0%)
2.0 21 (48.8%)
2.5 9 (20.9%)
3.0 10 (23.3%)
4.0 0 (0.0%)
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The percentage and average calculations as 
well as the Chi-Square test were used for statistics 
when indicated and Spearman Correlation was used 
to compare the scales’ scores, with significance level 
of  p < 0.05.
RESULTS
The 43 interviewed patients (72.1% of  them 
were men) presented an average age of  62.9 ± 10.7 
years old. The time elapsed at the beginning of  
symptoms and the interview was 8.81 ± 4.28 years. 
The caregivers interviewed (81.4% women) had an 
average age of  51.0 ± 13.5 years old. Table 1 shows 
the age distribution among the patients and caregiv-
ers, with their respective frequency.
The total score at the UPDRS scale was 63.2 
± 24.1, ranging from 18-146 points. Most patients 
with PD (48.8%) obtained score 2.0 into the Hoehn 
& Yahr scale, according to table 2; table 3 shows the 
frequency of  the patients according to the Schwab & 
England scale.
Comparing scores at the Hoehn & Yahr scale, 
it was found statistical significance between the gen-
ders (p = 0.0031), with average score for men equal 
to 2.44 and average score for women was 1.96. There 
was not statistical significance on the scores of  the 
other disease gradation scales related to the patients’ 
gender, as well as the caregivers’ age or gender.
The average score into the PDQ-39 scale was 
110.3 ± 27.0 points, ranging from 53-167 points. 
According to evaluation using the PDQ-39 scale, 
37.2% of  the patients felt embarrassed because of  
the disease, and 39.5% had difficulties on accepting 
the disease.
The evolution of  symptoms was feared by 
39.5% of  the patients. They also felt safe at the rela-
tionship with their caregivers in 48.8% of  the cases. 
The feeling of  depression or discouragement was 
seen in 51.2% of  the patients.
The average score into the CSS was 55.1 ± 
15.6 points, ranging from 32-92 points. The CSS 
showed that 55.8% of  the caregivers accepted the 
patients’ diagnosis, furthermore, all of  them had no 
embarrassed to talk about the disease; 46.5% were 
aware of  the dependency of  patients on them to 
perform several activities. Concerning the caregiv-
ers’ health, 83.7% of  them did not suffer injuries as-
sociated with the patient care, besides that, 86% felt 
well supported by health professionals. There was 
not statistical significance between the CSS and the 
caregivers’ gender (p = 0.6847) or age (p = 0.8912). 
A comparison among every score of  the UP-
DRS, Hoehn & Yahr, Schwab & England, PDQ-39 
or CSS, related with the time since at the beginning 
of  the symptoms of  PD, did not show statistical sig-
nificance for Kruskal-Wallis test.
Using the Spearman’s correlation, the com-
parison among the scales showed statistical signifi-
cance: UPDRS vs. PDQ-39 (p = 0.0001, r = 0.6057); 
Hoehn & Yahr vs. PDQ-39 (p = 0.0031, r = 0.4412); 
PDQ-39 vs. CSS (p = 0.0017, r = 0.4646). Others 
comparisons did not show statistical significance. 
The relation between the statistical significance 
scales is shown in graph 1 – the largest is the disease 
gradation (UPDRS and Hoenh & Yahr), largest the 
PDQ-39 degree is; the worse is the disease grade, the 
more caregiver is stressed.
The average score of  the patients at the UP-
DRS motor subscale was of  36.3 ± 16.2 points, while 
the bradykinesia subscale was of  15.0 ± 8.2 points. 
Using Spearman’s correlation, the comparison 
among these subscales and PDQ-39 showed statisti-
cal significance to the motor subscale (p = 0.0021; 
r = 0.4556) and to the bradykinesia subscale (p = 
0.0250; r = 0.3416), according to the graph 2, where 
the worse is the disease symptoms, a largest score of  
PDQ-39 is seen and the worse patient symptoms is.
Table 3. Frequency of  patients for each classification into the Schwab 
& England scale.
Schwab & England Frequency
40% 2 (4.7%)
50% 8 (18.6%)
60% 8 (18.6%)
70% 9 (20.9%)
80% 14 (32.6%)
90% 2 (4.7%)
Graphic 1. Comparison between scales UPDRS vs. PDQ-39, Hoehn 
& Yahr vs. PDQ-39, and PDQ-39 vs. CSS
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There was not statistical significance between 
motor and bradykinesia subscales and the CSS.
DISCUSSION
According to the literature, PD affects both 
genders similarly11,19, with the exception of  other 
two and our studies20,21, where there was male pre-
dominance among patients. An epidemiological 
comparison related to gender is not possible, once 
the patients were picked for this study and treated at 
a tertiary health service22.
In this study, there was a female predominance 
among the caregivers, as the preview literature11,21; 
however, the average age was lower than in other 
studies, without statistical significance in comparison 
with other variables. Other studies showed that male 
caregivers were more fragile when the illness had low-
est dimension23,24, which was not seen in this study.
Similarly to other studies6,11,20,21,25,26, the pa-
tients obtained scores 2.0 and 3.0 at the Hoehn & 
Yahr scale regarding the disease gradation. The score 
at the PDQ-39 scale was the same in all studies.
When the motor symptoms get worse, there 
was a decrease in the patients’ quality of  life, which 
implies the need to control the disease, but the pa-
tients’ clinical picture did not influence significantly 
on the caregivers’ well being.
The male patients had a small degree at the 
Hoehn & Yahr scale. Perhaps, they have taken lower 
drug dosages than females because of  their fewer 
complaints; the doses of  medication are reduced for 
them, even with severe degree of  the disease. How-
ever, this relation cannot be confirmed because this 
situation was not studied in this work.
Comparing both scales, there was statistical 
significance between the disease gradation (UPDRS 
and Hoehn & Yahr) and worsening of  the patients’ 
quality of  life, which led more stressed the caregiv-
ers, according to other studies6,11,21,25,26.
The increase of  motor symptoms had statis-
tical significance in comparison with the decrease 
of  patients’ quality of  life, but this did not change 
the stress score among the caregivers. Therefore, the 
disease clinical worsening was not the cause of  the 
increase of  caregivers’ stress, as observed at the care-
giver proportion who accepted well the patients’ di-
agnosis, according to the study by Happe & Berger21. 
This same study observed an increased severity of  
motor symptoms related to the worsening of  care-
givers’ sleep, which was not seen in this study.
Despite of  reports in literature about family 
destruction caused by the disease10,24,27, in this study, 
patients and caregivers had good structure, psycho-
logical support, and clarification about the disease.
The family support is vital to insert the pa-
tient in the society, and they should participate in it, 
improving quality of  life and decreasing depression 
symptoms, which have still harmful consequences 
for the caregiver.
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